Failure of a repeat course of cyclooxygenase inhibitor to close a PDA is a risk factor for developing chronic lung disease in ELBW infants

• Asıl Yazarlar: Adrouche-Amrani Lynda (Yazar), Green Robert S (Yazar), Gluck Karen M (Yazar), Lin Jing (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: BMC, 2012-01-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

<p>Abstract</p> <p>Background</p> <p>The optimal treatment regimen or protocol for managing a persistent patent ductus arteriosus (PDA) in extremely low birth weight (ELBW) infants has not been well established. This study was aimed at evaluating the failure rate of a c...